Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Colon CancerRectal Cancer
Interventions
DEVICE

SIR-spheres® (Selective Internal Radiation Therapy)

SIR-spheres® will be administered at 70%, 85% and 100% of the calculated individual patient dose (approximately 1 month prior to SIR-spheres® administration).The first cohort will receive SIRSpheres® at 70% of the individually calculated patient dose, the second will receive 85% of the calculated patient dose, and the third will receive 100% of the calculated patient dose.

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sirtex Medical

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER